Trial Profile
Comparative effect of Zoledronic acid and Denosumab on Bone Mineral Density (BMD) and TBS in patients with severe postmenopausal osteoporosis: A head to head comparison.
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 17 May 2016 New trial record
- 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases